Search
for
Sort by
Research 451–480 of 1000+
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Gut microbiota in alopecia areata
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Adverse cutaneous effects of psychotropic medications
- Low-level light therapy (LLLT) for cosmetics and dermatology
- Primary cicatricial alopecia and inflammatory bowel disease – is there a link?
- An Uncontrolled Case Series Using a Botanically Derived, β-Cyclodextrin Inclusion Complex in Two Androgenetic Alopecia-Affected Male Subjects
- Acne and acneiform eruptions
- Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China
- Isotretinoin
- Plakophilin 1 suppresses keratinocyte innate immune responses through DExD/H helicases
- Prevalence and Clinical Spectrum of Dermatologic Conditions in Renal Transplant Recipients: A 10-Year Retrospective Cross-Sectional Study
- Effects of Psychological Stress on Skin Aging: A Literature review
- Management of Indralupta with Prachana and External Applications - A Case Report
- Efficacy and safety of topical 5% minoxidil in treatment of androgenetic alopecia
- Case Series and Literature Review on Tofacitinib for Treating Severe Alopecia Areata
- Association between air quality index and risk of alopecia areata: A nationwide population-based cohort study
- Assessment of Serum Level of Brain-Derived Neurotrophic Factor (BDNF) In Pediatric Alopecia Areata: A Case - Control Study
- Soapnut Shampoo: A Natural and sustainable hair care shampoo
- Evidence-Based Homeopathy: A case study on alopecia areata in a 6-year-old child
- Vaping Culture and Cutaneous Health: A Trend with Skin-Deep Consequences
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- The prevalence of thyroid function test abnormalities and serum thyroid autoantibodies in vitiligo and alopecia areata patients in Saudi Arabian population
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- 708 SIG-1451: A topical anti-inflammatory new chemical entity for atopic dermatitis (AD)
- 709 Nitric oxide-releasing topical therapeutic agent for atopic dermatitis
- CLINICAL STUDY OF CUTANEOUS MANIFESTATION OF GERIATRIC AGE GROUP
- Festschrift in honor of the 65th birthday of Dr. Howard I. Maibach
- Skin involvement in systemic lupus erythematosus: a review article
- Effective high-throughput isolation of enriched platelets and circulating pro-angiogenic cells to accelerate skin-wound healing